Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Branched-chain keto acids promote an immune-suppressive and neurodegenerative microenvironment in leptomeningeal disease

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.18.572239Source: DataRank Database

Branched-chain keto acids promote an immune-suppressive and neurodegenerative microenvironment in leptomeningeal disease is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: greenTopics (12)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (22)

Yuan Ren ORCID,Ronak Kundalia ORCID,Hasan Alhaddad ORCID,Zhihua Chen ORCID,Gerald Wallace

Live enrichment

PubMed:38187773 OpenAlex:https://openalex.org/W4389954717

National Institutes of Health

Grant: 5R00CA226679-05

Defining the Role of Metabolic Heterogeneity in Melanoma Dissemination and Therapy Escape

National Institutes of Health

Grant: 5R21CA274060-02

Defining and targeting the immune-suppressive metabolic microenvironment of leptomeningeal melanoma metastases

National Institutes of Health

Grant: 5R01CA244328-04

Neurocognitive and Patient-Reported Outcomes after Chimeric Antigen Receptor T-Cell Therapy: A Controlled Comparison

National Institutes of Health

Grant: 3P30CA076292-24S2

Moffitt Cancer Center Support Grant

greenLicense: cc-by-nc-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2023/12/18/2023.12.18.572239.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.12.18.572239

repositoryhttp://dx.doi.org/10.1101/2023.12.18.572239

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38187773

Fields of Study

Brain Metastases and TreatmentHistone Deacetylase Inhibitors ResearchCancer Immunotherapy and Biomarkers03 medical and health sciences0302 clinical medicine

Keywords

Immune systemDiseaseImmunologyMedicineCancer researchPathologyArticle

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being